Resultados de la búsqueda 351-360 of 10417 for Moderate acute malnutrition
... acute ischemic stroke or high risk TIA (1) reduces recurrent stroke, acute ... To further investigate biomarkers in CSF as possible predictors for mild cognitive ...
Los investigadores de Mayo Clinic estudian la enfermedad de Alzheimer, mild cognitive impairmenty otras afecciones que afectan la memoria y el pensamiento.
Giving inotuzumab ozogamicin with chemotherapy may work better in treating young adults with B acute lymphoblastic leukemia. Evaluating Markers which Might be a ...
Rochester, Minn. The purpose of this study is to follow Mayo Clinic patients with severe brachial plexus injuries who underwent upper limb amputation. Genomic ...
The purpose of this study is to evaluate immune profile of Acute Myeloid Leukemia (AML) patients receiving Venetoclax plus Azacitidine induction chemotherapy.
We hope to use these samples to find out why some patients still have cancer after they have completed neoadjuvant anticancer therapy. The Pediatric Acute ...
The purpose of this study is to evaluate key clinical, microbial, histological, and skin imaging biomarkers in patients with moderate-to-severe atopic ...
... acutely to MCF with mild COVID-19 and patients presenting with severe COVID-19. This will be accomplished by utilizing the the immunoSEQ Human T-cell ...
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?